The pharmaceutical company Gossamer Bio, celebrates a significant achievement with the publication of its TORREY Phase 2 study results in the esteemed Lancet Respiratory Medicine journal.
Translate (automatic translation - please excuse any mistakes) »
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.